)
Lepu Medical Technology Co (300003) investor relations material
Lepu Medical Technology Co Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for H1 2026 was ¥3.21 billion, down 4.61% year-over-year; net profit attributable to shareholders was ¥499 million, down 27.71% year-over-year.
Excluding a one-time convertible bond redemption expense, adjusted net profit fell 14.79% year-over-year.
The company maintained a strong position in cardiovascular devices, expanded innovation in neuroregulation and brain-machine interface, and advanced its internationalization strategy.
Cash dividend of ¥1.6275 per 10 shares proposed, totaling ¥300 million.
Financial highlights
Operating income: ¥3.21 billion, down 4.61% year-over-year.
Net profit attributable to shareholders: ¥499 million, down 27.71% year-over-year.
Adjusted net profit (excluding one-off bond expense): ¥564 million, down 14.79% year-over-year.
Operating cash flow: ¥633 million, down 0.60% year-over-year.
Basic and diluted EPS: ¥0.2710, down 27.69% year-over-year.
R&D investment: ¥604 million, up 13.40% year-over-year.
Outlook and guidance
The company will continue to focus on innovation, consumer healthcare, and international expansion.
Plans to accelerate new product development and commercialization, especially in high-value consumables and innovative drugs.
International business and consumer healthcare expected to be new growth drivers.
- 2025 saw record profit growth and strong innovation momentum amid industry transformation.300003
Q4 2025 - Revenue and net profit declined, but adjusted profit was resilient amid procurement pressures.300003
Q1 2026 - Q3 net profit surged 176.18% year-over-year, driven by strong revenue and cash flow growth.300003
Q3 2025 - Revenue and net profit were stable, with strong cash flow and continued innovation leadership.300003
Q2 2025 - Q3 saw steep profit and revenue declines, offset by growth in core medical device segments.300003
Q3 2024 - Revenue and profit fell, but cardiovascular and overseas segments grew; innovation pipeline advanced.300003
Q2 2024 - Revenue and profit declined sharply, but innovation and global expansion drive future growth.300003
Q4 2024 - Revenue declined year-over-year but sequential growth and strong cash flow marked Q1 2025.300003
Q1 2025
Next Lepu Medical Technology Co earnings date
Next Lepu Medical Technology Co earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage